세계의 갑상선 안병증(TED) 시장 보고서(2025년)

Thyroid Eye Disease (TED) Global Market Report 2025

US $ 4,490 ￦ 6,253,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,039,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,824,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

갑상선 안병증(TED) 시장 규모는 앞으로 수 년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.6%로 29억 7,000만 달러로 성장할 것으로 예상됩니다. 예측 기간 동안의 성장은 바세도우 병 유병률 증가, 다양한 산업에서의 자금 조달 증가, 헬스케어 지출 증가, 갑상선 호르몬 보충 요법의 이용 확대, 갑상선 질환의 이환율의 상승에 의해 견인될 가능성이 있습니다. 이 기간의 주요 동향에는 기술 발전, 연구 개발 활동 확대, 신약 개발, 치료 옵션 개선, 새로운 수술 절차 도입 등이 있습니다.

갑상선 질환의 유병률 증가는 갑상선 안병증(TED) 시장의 확대를 촉진할 것으로 예측됩니다. 갑상선 질환은 갑상선의 기능을 방해하여 호르몬 불균형이나 갑상선 기능 저하증, 갑상선 기능 항진증, 갑상선종, 갑상선 안병증 등의 상태를 일으키는 병리입니다. 갑상선 질환의 이환율 증가는 요오드 섭취량 증가, 자가면역 질환, 유전적 소인, 진단률의 향상으로 이어지는 인지도의 향상 등의 요인에 기인합니다. 갑상선 안병증(TED)은 바세도우병의 심각하고 일반적인 합병증이기 때문에 갑상선 질환의 사례 수를 증가시키는데 중요한 역할을 하고 있으며, 갑상선 관련 질환의 전반적인 부담과 인지도 향상에 기여하고 있습니다. 예를 들어 2024년 5월 캐나다를 거점으로 하는 비영리단체인 캐나다암협회는 2024년 캐나다에서 기본 추정 6,600 건의 갑상선암이 새롭게 진단될 것으로 예상되며, 약 280건의 사망이 예측된다고 보고했습니다. 그 결과, 갑상선 질환의 유병률 증가로 갑상선 안병증(TED) 시장 성장이 촉진되고 있습니다.

갑상선 안병증(TED) 시장의 주요 기업은 단일클론항체 요법과 같은 혁신적인 치료법의 개발을 선호하고, 염증을 억제하고, 눈꺼풀 뇌하수를 개선하고, 환자의 결과 전체를 향상시키는 보다 효과적이고 적극적인 솔루션을 제공합니다. 신체 요법은 특정 병원체와 비정상적인 세포를 인식하고 중화하는 면역계의 능력을 모방하도록 설계된 실험실에서 조작된 항체를 포함합니다. 위협할 수 있는 희귀한 자가면역 질환인 활동성 갑상선 안병증(TED)의 치료로서 TEPEZZA (teprotumumab)를 승인했다고 발표했습니다. 테페자(TEPEZA)는 TED에 특화된 최초이자 유일한 FDA 승인 치료제로, 염증, 부기 및 기타 쇠약해지는 증상을 줄이는 데 도움이 되는 표적 치료제를 제공합니다

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 갑상선 안병증(TED) PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 갑상선 안병증(TED) 시장 : 성장률 분석
• 세계의 갑상선 안병증(TED) 시장 실적: 규모와 성장, 2019-2024년
• 세계의 갑상선 안병증(TED) 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 갑상선 안병증(TED) 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 갑상선 안병증(TED) 시장 : 치료 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 의료
• 수술
• 내과와 수술의 조합
• 세계의 갑상선 안병증(TED) 시장 : 병의 중증도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 경도
• 중간
• 심도
• 세계의 갑상선 안병증(TED) 시장 : 약제 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 생물제제
• 소분자
• 기타 약제 유형
• 세계의 갑상선 안병증(TED) 시장 : 투여 경로별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 경구
• 정맥내
• 피하
• 세계의 갑상선 안병증(TED) 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 병원
• 클리닉
• 기타
• 세계의 갑상선 안병증(TED) 시장 : 의료별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 코르티코스테로이드
• 테프로툼맙
• 항갑상선약
• 기타 의료 처치
• 세계의 갑상선 안병증(TED) 시장 : 외과별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 안와 감압 수술
• 눈꺼풀 수술
• 사시 수술
• 세계의 갑상선 안병증(TED) 시장 : 내과와 외과 조합별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 코르티코스테로이드와 안와 감압술 병용
• 테프로툼맙과 눈꺼풀 수술 병용
• 기타 복합 접근

제7장 지역별/국가별 분석

• 세계의 갑상선 안병증(TED) 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 갑상선 안병증(TED) 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 갑상선 안병증(TED) 시장 : 경쟁 구도
• 갑상선 안병증(TED) 시장 : 기업 프로파일
  • Hoffmann-La Roche AG
  • Amgen Inc.
  • Genentech Inc.
  • Horizon Therapeutics plc
  • Pierre Fabre SA

제31장 기타 주요 기업 및 혁신 기업

• Innovent Biologics Inc.
• ACELYRIN Inc.
• Soleo Health
• Zai Lab Limited
• HanAll Biopharma Co. Ltd.
• Tourmaline Bio Inc.
• Zenas BioPharma Inc.
• Immunovant Inc.
• Verana Health
• Harbour BioMed(Guangzhou) Co. Ltd.
• Sling Therapeutics Inc.
• Crinetics Pharmaceuticals Inc.
• Lassen Therapeutics Inc.
• Viridian Therapeutics Inc.
• Minghui Pharmaceutical Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

• 갑상선 안병증(TED) 시장, 2029년 : 새로운 기회를 제공하는 국가
• 갑상선 안병증(TED) 시장, 2029년 : 새로운 기회를 제공하는 부문
• 갑상선 안병증(TED) 시장, 2029년 : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

SHW

영문 목차

영문목차

Thyroid eye disease (TED), also known as Graves' Orbitopathy, is an autoimmune disorder marked by inflammation and swelling of the tissues surrounding the eyes, often linked to thyroid conditions. TED can lead to symptoms such as bulging eyes, double vision, and eye discomfort.

The primary treatment approaches for TED include medical, surgical, and a combination of both. Medical management typically involves corticosteroids, immunosuppressive drugs, and biologic therapies to reduce inflammation, alleviate symptoms, and prevent disease progression. Treatment is customized based on disease severity, classified into mild, moderate, and severe stages. The drugs used belong to various categories, including biologics, small molecules, and others. They are administered through different routes, such as oral, intravenous, and subcutaneous methods, and are utilized by various end users, including hospitals, clinics, and other healthcare facilities.

The thyroid eye disease (TED) market research report is one of a series of new reports from The Business Research Company that provides thyroid eye disease (TED) market statistics, including the thyroid eye disease (TED) industry global market size, regional shares, competitors with the thyroid eye disease (TED) market share, detailed thyroid eye disease (TED) market segments, market trends, and opportunities, and any further data you may need to thrive in the thyroid eye disease (TED) industry. This thyroid eye disease (TED) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The thyroid eye disease (TED) market size has grown strongly in recent years. It will grow from $2.15 billion in 2024 to $2.30 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth during the historic period can be attributed to the rising incidence of thyroid disorders, a growing emphasis on patient-centered care, increasing demand for cosmetic procedures, a higher prevalence of the disease, and the expansion of treatment options for TED.

The thyroid eye disease (TED) market size is expected to see strong growth in the next few years. It will grow to $2.97 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth during the forecast period can be driven by the rising prevalence of Graves' disease, increased funding across various industries, growing healthcare expenditure, greater use of thyroid hormone replacement therapy, and a higher incidence of thyroid disease. Key trends in this period include technological advancements, expanding R&D activities, the development of novel drugs, improvements in treatment options, and the introduction of new surgical techniques.

The increasing prevalence of thyroid disorders is expected to drive the expansion of the thyroid eye disease (TED) market. Thyroid disorders are medical conditions that disrupt the function of the thyroid gland, leading to hormonal imbalances and conditions such as hypothyroidism, hyperthyroidism, goiter, and thyroid eye disease. The rising incidence of thyroid disorders is attributed to factors such as increased iodine intake, autoimmune diseases, genetic predisposition, and improved awareness leading to higher diagnostic rates. Thyroid Eye Disease (TED) plays a significant role in the growing number of thyroid disorder cases, as it is a serious and common complication of Graves' disease, contributing to the overall burden and awareness of thyroid-related conditions. For example, in May 2024, the Canadian Cancer Society, a Canada-based non-profit organization, reported that an estimated 6,600 new cases of thyroid cancer are expected to be diagnosed in Canada in 2024, with approximately 280 projected fatalities. As a result, the increasing prevalence of thyroid disorders is fueling the growth of the thyroid eye disease (TED) market.

Leading companies in the thyroid eye disease (TED) market are prioritizing the development of innovative treatments, such as monoclonal antibody therapies, to provide more effective, targeted solutions that reduce inflammation, improve proptosis, and enhance overall patient outcomes. Monoclonal antibody therapies involve laboratory-engineered antibodies designed to mimic the immune system's ability to recognize and neutralize specific pathogens or abnormal cells. For instance, in September 2024, Amgen Inc., a US-based biotechnology company, announced that Japan's Ministry of Health, Labour and Welfare (MHLW) had approved TEPEZZA (teprotumumab) for the treatment of active thyroid eye disease (TED), a rare and potentially vision-threatening autoimmune disorder. TEPEZZA is the first and only FDA-approved therapy specifically for TED, offering a targeted treatment that helps reduce inflammation, swelling, and other debilitating symptoms associated with the disease. This approval is particularly significant for patients in Japan, as it introduces an effective new option for managing TED, a progressive condition that can cause severe eye bulging, vision impairment, and eye pain.

In October 2023, Amgen Inc., a US-based biopharmaceutical company, acquired Horizon Therapeutics plc for an undisclosed amount. This acquisition strengthens Amgen's rare and inflammatory disease portfolio by integrating Horizon's key therapies, expanding its global reach, and driving innovation for long-term growth. Horizon Therapeutics plc, an Ireland-based company, specializes in treatments for rare autoimmune and inflammatory diseases.

Major players in the thyroid eye disease (ted) market are Hoffmann-La Roche AG, Amgen Inc., Genentech Inc., Horizon Therapeutics plc, Pierre Fabre S.A., Innovent Biologics Inc., ACELYRIN Inc., Soleo Health, Zai Lab Limited, HanAll Biopharma Co. Ltd., Tourmaline Bio Inc., Zenas BioPharma Inc., Immunovant Inc., Verana Health, Harbour BioMed (Guangzhou) Co. Ltd., Sling Therapeutics Inc., Crinetics Pharmaceuticals Inc., Lassen Therapeutics Inc., Viridian Therapeutics Inc., Minghui Pharmaceutical Inc.

North America was the largest region in the thyroid eye disease (TED) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in thyroid eye disease (TED) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the thyroid eye disease (TED) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The thyroid eye disease (TED) market includes revenues earned by entities by providing services such as diagnosis services, pharmaceutical services, surgical services, support, and counseling services and related products including thyroid hormone replacement therapy, immunosuppressive drugs, surgical products, and devices. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Thyroid Eye Disease (TED) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on thyroid eye disease (ted) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for thyroid eye disease (ted) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The thyroid eye disease (ted) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Medical; Surgical; Combination Of Medical And Surgical
• 2) By Disease Severity: Mild; Moderate; Severe
• 3) By Drug Type: Biologics; Small Molecules; Others Drug Type
• 4) By Route Of Administration: Oral; Intravenous; Subcutaneous
• 5) By End User: Hospitals; Clinics; Other End Users
• Subsegments:
• 1) By Medical: Corticosteroids; Teprotumumab; Antithyroid Medications; Other Medical Treatments
• 2) By Surgical: Orbital Decompression Surgery; Eyelid Surgery; Strabismus Surgery
• 3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression; Combination of Teprotumumab and Eyelid Surgery; Other Combined Approaches
• Companies Mentioned: Hoffmann-La Roche AG; Amgen Inc.; Genentech Inc.; Horizon Therapeutics plc; Pierre Fabre S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Thyroid Eye Disease (TED) Market Characteristics

3. Thyroid Eye Disease (TED) Market Trends And Strategies

4. Thyroid Eye Disease (TED) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Thyroid Eye Disease (TED) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Thyroid Eye Disease (TED) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Thyroid Eye Disease (TED) Market Growth Rate Analysis
• 5.4. Global Thyroid Eye Disease (TED) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Thyroid Eye Disease (TED) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Thyroid Eye Disease (TED) Total Addressable Market (TAM)

6. Thyroid Eye Disease (TED) Market Segmentation

• 6.1. Global Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical
• Surgical
• Combination Of Medical And Surgical
• 6.2. Global Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mild
• Moderate
• Severe
• 6.3. Global Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologics
• Small Molecules
• Others Drug Type
• 6.4. Global Thyroid Eye Disease (TED) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Subcutaneous
• 6.5. Global Thyroid Eye Disease (TED) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other End Users
• 6.6. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Medical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Teprotumumab
• Antithyroid Medications
• Other Medical Treatments
• 6.7. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Orbital Decompression Surgery
• Eyelid Surgery
• Strabismus Surgery
• 6.8. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Combination Of Medical And Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Combination Of Corticosteroids And Orbital Decompression
• Combination Of Teprotumumab And Eyelid Surgery
• Other Combined Approaches

7. Thyroid Eye Disease (TED) Market Regional And Country Analysis

• 7.1. Global Thyroid Eye Disease (TED) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Thyroid Eye Disease (TED) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Thyroid Eye Disease (TED) Market

• 8.1. Asia-Pacific Thyroid Eye Disease (TED) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Thyroid Eye Disease (TED) Market

• 9.1. China Thyroid Eye Disease (TED) Market Overview
• 9.2. China Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Thyroid Eye Disease (TED) Market

• 10.1. India Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Thyroid Eye Disease (TED) Market

• 11.1. Japan Thyroid Eye Disease (TED) Market Overview
• 11.2. Japan Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Thyroid Eye Disease (TED) Market

• 12.1. Australia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Thyroid Eye Disease (TED) Market

• 13.1. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Thyroid Eye Disease (TED) Market

• 14.1. South Korea Thyroid Eye Disease (TED) Market Overview
• 14.2. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Thyroid Eye Disease (TED) Market

• 15.1. Western Europe Thyroid Eye Disease (TED) Market Overview
• 15.2. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Thyroid Eye Disease (TED) Market

• 16.1. UK Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Thyroid Eye Disease (TED) Market

• 17.1. Germany Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Thyroid Eye Disease (TED) Market

• 18.1. France Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Thyroid Eye Disease (TED) Market

• 19.1. Italy Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Thyroid Eye Disease (TED) Market

• 20.1. Spain Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Thyroid Eye Disease (TED) Market

• 21.1. Eastern Europe Thyroid Eye Disease (TED) Market Overview
• 21.2. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Thyroid Eye Disease (TED) Market

• 22.1. Russia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Thyroid Eye Disease (TED) Market

• 23.1. North America Thyroid Eye Disease (TED) Market Overview
• 23.2. North America Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Thyroid Eye Disease (TED) Market

• 24.1. USA Thyroid Eye Disease (TED) Market Overview
• 24.2. USA Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Thyroid Eye Disease (TED) Market

• 25.1. Canada Thyroid Eye Disease (TED) Market Overview
• 25.2. Canada Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Thyroid Eye Disease (TED) Market

• 26.1. South America Thyroid Eye Disease (TED) Market Overview
• 26.2. South America Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Thyroid Eye Disease (TED) Market

• 27.1. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Thyroid Eye Disease (TED) Market

• 28.1. Middle East Thyroid Eye Disease (TED) Market Overview
• 28.2. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Thyroid Eye Disease (TED) Market

• 29.1. Africa Thyroid Eye Disease (TED) Market Overview
• 29.2. Africa Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Thyroid Eye Disease (TED) Market Competitive Landscape And Company Profiles

• 30.1. Thyroid Eye Disease (TED) Market Competitive Landscape
• 30.2. Thyroid Eye Disease (TED) Market Company Profiles
  • 30.2.1. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Genentech Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Horizon Therapeutics plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Pierre Fabre S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Thyroid Eye Disease (TED) Market Other Major And Innovative Companies

• 31.1. Innovent Biologics Inc.
• 31.2. ACELYRIN Inc.
• 31.3. Soleo Health
• 31.4. Zai Lab Limited
• 31.5. HanAll Biopharma Co. Ltd.
• 31.6. Tourmaline Bio Inc.
• 31.7. Zenas BioPharma Inc.
• 31.8. Immunovant Inc.
• 31.9. Verana Health
• 31.10. Harbour BioMed (Guangzhou) Co. Ltd.
• 31.11. Sling Therapeutics Inc.
• 31.12. Crinetics Pharmaceuticals Inc.
• 31.13. Lassen Therapeutics Inc.
• 31.14. Viridian Therapeutics Inc.
• 31.15. Minghui Pharmaceutical Inc.

32. Global Thyroid Eye Disease (TED) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Thyroid Eye Disease (TED) Market

34. Recent Developments In The Thyroid Eye Disease (TED) Market

35. Thyroid Eye Disease (TED) Market High Potential Countries, Segments and Strategies

• 35.1 Thyroid Eye Disease (TED) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Thyroid Eye Disease (TED) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Thyroid Eye Disease (TED) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료